health x platform hosted a group conference call with investors and analysts on June 12, 2026, at 4:00 PM IST. The meeting focused on discussing the company's performance for the quarter and year ended March 31, 2026, followed by an interactive question and answer session with the senior management.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has ensured that the proceedings are accessible to stakeholders for transparency.

The audio recording of the conference call for Quarter 4 of the Financial Year 2025-26 is now available. Interested parties can access the recording via the official website of the company.

Health X Platform has approved a Composite Scheme of Arrangement and Amalgamation involving Microsec Resources Private Limited, Innogrow Technologies Limited, and Sastasundar Healthbuddy Limited. The restructuring aims to consolidate the healthcare services business into a single entity and create a focused financial services entity, thereby simplifying the corporate structure and enhancing shareholder value. The scheme involves the demerger of the financial services undertaking from Health X Platform Limited into Microsec Resources Private Limited, the amalgamation of Innogrow Technologies Limited with Microsec Resources Private Limited, and the amalgamation of Sastasundar Healthbuddy Limited with Health X Platform Limited.

Share Exchange Ratios

The Board has established specific share entitlement and exchange ratios for the scheme. For the demerger of the finance undertaking, Microsec Resources Private Limited will issue 1 equity share of INR 10 each for every 3 equity shares of INR 10 each held in Health X Platform Limited. Pursuant to the merger of Sastasundar Healthbuddy Limited with Health X Platform Limited, the latter will issue 85,12,168 equity shares of INR 10 each to the public shareholders of the former for 45,75,830 equity shares held. No shares will be issued for the amalgamation of Innogrow Technologies Limited as it is a wholly owned subsidiary.

Shareholding Pattern Changes

Upon effectiveness of the scheme, the shareholding pattern of Health X Platform Limited will change significantly. The public shareholding will increase from 25.93% to 41.57%, while the promoter and promoter group holding will decrease from 74.07% to 58.43%. The total number of shares will rise to 4,03,22,668. Microsec Resources Private Limited will be converted into a public company, and its shares will be listed on BSE and NSE, with public shareholding at 25.93%.

Key Financial Metrics

The demerged financial services division reported a turnover of INR 1,519.05 lakhs for the year ended March 31, 2026, representing 1.10% of the total consolidated turnover of INR 1,37,753.67 lakhs. The appointed date for the scheme is April 1, 2026, while the effective date will be determined upon the filing of the National Company Law Tribunal's sanction order with the Registrar of Companies.

Implementation Timelines

Implementation of the scheme is expected to take around 12 – 14 months subject to the receipt of the requisite approvals. Key milestones include Board Approval in June 2026, filing with Stock Exchanges and RBI, receipt of approvals in Q3 FY26-27, NCLT approval in Q4 FY26-27, and an effective date anticipated in July 2027. The scheme is subject to approvals from BSE Limited, National Stock Exchange of India, SEBI, NCLT, RBI, and respective shareholders and creditors.